e-learning
resources
Monograph
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Abscess of the lung: current therapeutic options
Kalliopi Athanassiadi, Radoslav Jakovic´, Nikolaos Siafakas
Source:
Eur Respir Monogr 2013; 61: 81-89
Journal Issue:
Complex Pleuropulmonary Infections
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kalliopi Athanassiadi, Radoslav Jakovic´, Nikolaos Siafakas. Abscess of the lung: current therapeutic options. Eur Respir Monogr 2013; 61: 81-89
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Endoscopic lung volume reduction: options and challenges
Source: International Congress 2014 – PG10 Interventional pulmonology
Year: 2014
Inflammatory pseudotumors of the lung in the adult: surgical options
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004
Treatment of interstitial lung diseases: current approaches and future directions
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021
Bronchiectasis: new therapies and perspectives
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018
Lung disease induced by newer therapies for lung cancer: an update
Source: Annual Congress 2006 - Drug-induced lung injury – new aspects
Year: 2006
Lung abscess – still a surgical management?
Source: Eur Respir J 2006; 28: Suppl. 50, 271s
Year: 2006
Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020
Therapeutic strategies: what treatment for what patient
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008
Biomarkers in early-detection of lung cancer: current concepts
Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts
Year: 2021
Pulmonary hydatidosis: surgical options
Source: Eur Respir J 2006; 28: Suppl. 50, 275s
Year: 2006
Peripheral lung lesions: what are the options for obtaining a tissue diagnosis?
Source: International Congress 2014 – PG10 Interventional pulmonology
Year: 2014
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Bacteriological and therapeutic features of lung abscess
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches
Source: Eur Respir J 2006; 28: 463-465
Year: 2006
Tuberculosis: therapeutic armamentarium
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Endpoints in IPF and lung cancer trials: controversies and perspectives
Source: Research Seminar 2015
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept